An Organ-On-Chip (OOC) is a multi-channel 3-D microfluidic cell culture chip that simulates the activities, mechanics and physiological response of entire organs and organ systems, a type of artificial organ. It constitutes the subject matter of significant biomedical engineering research, more precisely in bio-MEMS. The convergence of labs-on-chips (LOCs) and cell biology has permitted the study of human physiology in an organ-specific context, introducing a novel model of in vitro multicellular human organisms. One day, they will perhaps abolish the need for animals in drug development and toxin testing. Organ-On-Chip technology not only incorporates multiple cell types but also involves engineering aspects, such as the guided spatial confinement of cells or the incorporation of sensors and microfluidic channels. The primary focus of Organ-On-Chip technology is the re-creation of three key aspects of human physiology: the multicellular vascular or epithelial interfaces of organs (for example, blood vessel networks, lung and gut), which function as barriers in tissues; the tissue-level organization of parenchymal cells (for example, liver, heart, skeletal muscle and tumours), which are responsible for the key functional properties of an organ; and the systematic interaction of multiple organs (for example, drug absorption, distribution, metabolism and elimination involving the gut, circulation, liver and kidney). In addition, the Blood-Brain Barrier is definitely more complex than a simple wall, controlling the passage of most solute that enters or leaves the brain. To address how this molecular sieve affects neural activity, some researchers have simulated the interaction between blood vessels and brain tissue on a series of interconnected "organ chips" when connected through this Blood-Brain Barrier (BBB) model. Endothelial cells, pericytes, astrocytes and neurons alter their gene expression. These technologies will achieve even more rapid development and application.
The global Human Organs-on-Chips market was valued at US$ 122 million in 2023 and is anticipated to reach US$ 796 million by 2030, witnessing a CAGR of 31.2% during the forecast period 2024-2030.
Global key players of Human Organs-on-Chips include Emulate, Mimetas, TissUse, Valo Health and CN Bio Innovations. The top five players hold a share over 55%. North America is the largest market, has a share about 42%, followed by Europe, and Asia-Pacific, with share 35% and 18%, separately. In terms of product type, Liver-on-a-chip is the largest segment, occupied for a share of 26%, and in terms of application, Pharmaceutical & Biotechnology Companies has a share about 70%.
This report aims to provide a comprehensive presentation of the global market for Human Organs-on-Chips, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Organs-on-Chips.
The Human Organs-on-Chips market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Organs-on-Chips market comprehensively. Regional market sizes, concerning products by Type, by End User, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Organs-on-Chips companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by End User, and by regions.
麻豆原创 Segmentation
By Company
Emulate
Mimetas
TissUse
Valo Health
CN Bio Innovations
Hesperos
Draper Laboratory
Nortis
Micronit Microtechnologies B.V.
Kirkstall
Cherry Biotech SAS
Else Kooi Laboratory
Altis Biosystems
Bi/ond
Netri
Xona Microfluidics
SynVivo
Beijing Daxiang Biotech
AVATARGET
Suzhou Jiyan Biopharmaceutical
Segment by Type
Brain-on-a-chip
Liver-on-a-chip
Kidney-on-a-chip
Lung-on-a-chip
Heart-on-a-chip
Intestine-on-a-chip
Vessel-on-a-chip
Other Organs
Segment by End User
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Cosmetics Industry
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by End User, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Human Organs-on-Chips company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by End User, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Human Organs-on-Chips 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Brain-on-a-chip
1.2.3 Liver-on-a-chip
1.2.4 Kidney-on-a-chip
1.2.5 Lung-on-a-chip
1.2.6 Heart-on-a-chip
1.2.7 Intestine-on-a-chip
1.2.8 Vessel-on-a-chip
1.2.9 Other Organs
1.3 麻豆原创 by End User
1.3.1 Global Human Organs-on-Chips 麻豆原创 Growth by End User: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 Academic & Research Institutes
1.3.4 Cosmetics Industry
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Human Organs-on-Chips 麻豆原创 Perspective (2019-2030)
2.2 Global Human Organs-on-Chips Growth Trends by Region
2.2.1 Global Human Organs-on-Chips 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Human Organs-on-Chips Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Human Organs-on-Chips Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Human Organs-on-Chips 麻豆原创 Dynamics
2.3.1 Human Organs-on-Chips Industry Trends
2.3.2 Human Organs-on-Chips 麻豆原创 Drivers
2.3.3 Human Organs-on-Chips 麻豆原创 Challenges
2.3.4 Human Organs-on-Chips 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Human Organs-on-Chips Players by Revenue
3.1.1 Global Top Human Organs-on-Chips Players by Revenue (2019-2024)
3.1.2 Global Human Organs-on-Chips Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Human Organs-on-Chips 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Human Organs-on-Chips Revenue
3.4 Global Human Organs-on-Chips 麻豆原创 Concentration Ratio
3.4.1 Global Human Organs-on-Chips 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Organs-on-Chips Revenue in 2023
3.5 Global Key Players of Human Organs-on-Chips Head office and Area Served
3.6 Global Key Players of Human Organs-on-Chips, Product and Application
3.7 Global Key Players of Human Organs-on-Chips, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Human Organs-on-Chips Breakdown Data by Type
4.1 Global Human Organs-on-Chips Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Human Organs-on-Chips Forecasted 麻豆原创 Size by Type (2025-2030)
5 Human Organs-on-Chips Breakdown Data by End User
5.1 Global Human Organs-on-Chips Historic 麻豆原创 Size by End User (2019-2024)
5.2 Global Human Organs-on-Chips Forecasted 麻豆原创 Size by End User (2025-2030)
6 North America
6.1 North America Human Organs-on-Chips 麻豆原创 Size (2019-2030)
6.2 North America Human Organs-on-Chips 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Human Organs-on-Chips 麻豆原创 Size by Country (2019-2024)
6.4 North America Human Organs-on-Chips 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Human Organs-on-Chips 麻豆原创 Size (2019-2030)
7.2 Europe Human Organs-on-Chips 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Human Organs-on-Chips 麻豆原创 Size by Country (2019-2024)
7.4 Europe Human Organs-on-Chips 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Human Organs-on-Chips 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific Human Organs-on-Chips 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Human Organs-on-Chips 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific Human Organs-on-Chips 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Human Organs-on-Chips 麻豆原创 Size (2019-2030)
9.2 Latin America Human Organs-on-Chips 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Human Organs-on-Chips 麻豆原创 Size by Country (2019-2024)
9.4 Latin America Human Organs-on-Chips 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Human Organs-on-Chips 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa Human Organs-on-Chips 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Human Organs-on-Chips 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa Human Organs-on-Chips 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Emulate
11.1.1 Emulate Company Details
11.1.2 Emulate Business Overview
11.1.3 Emulate Human Organs-on-Chips Introduction
11.1.4 Emulate Revenue in Human Organs-on-Chips Business (2019-2024)
11.1.5 Emulate Recent Development
11.2 Mimetas
11.2.1 Mimetas Company Details
11.2.2 Mimetas Business Overview
11.2.3 Mimetas Human Organs-on-Chips Introduction
11.2.4 Mimetas Revenue in Human Organs-on-Chips Business (2019-2024)
11.2.5 Mimetas Recent Development
11.3 TissUse
11.3.1 TissUse Company Details
11.3.2 TissUse Business Overview
11.3.3 TissUse Human Organs-on-Chips Introduction
11.3.4 TissUse Revenue in Human Organs-on-Chips Business (2019-2024)
11.3.5 TissUse Recent Development
11.4 Valo Health
11.4.1 Valo Health Company Details
11.4.2 Valo Health Business Overview
11.4.3 Valo Health Human Organs-on-Chips Introduction
11.4.4 Valo Health Revenue in Human Organs-on-Chips Business (2019-2024)
11.4.5 Valo Health Recent Development
11.5 CN Bio Innovations
11.5.1 CN Bio Innovations Company Details
11.5.2 CN Bio Innovations Business Overview
11.5.3 CN Bio Innovations Human Organs-on-Chips Introduction
11.5.4 CN Bio Innovations Revenue in Human Organs-on-Chips Business (2019-2024)
11.5.5 CN Bio Innovations Recent Development
11.6 Hesperos
11.6.1 Hesperos Company Details
11.6.2 Hesperos Business Overview
11.6.3 Hesperos Human Organs-on-Chips Introduction
11.6.4 Hesperos Revenue in Human Organs-on-Chips Business (2019-2024)
11.6.5 Hesperos Recent Development
11.7 Draper Laboratory
11.7.1 Draper Laboratory Company Details
11.7.2 Draper Laboratory Business Overview
11.7.3 Draper Laboratory Human Organs-on-Chips Introduction
11.7.4 Draper Laboratory Revenue in Human Organs-on-Chips Business (2019-2024)
11.7.5 Draper Laboratory Recent Development
11.8 Nortis
11.8.1 Nortis Company Details
11.8.2 Nortis Business Overview
11.8.3 Nortis Human Organs-on-Chips Introduction
11.8.4 Nortis Revenue in Human Organs-on-Chips Business (2019-2024)
11.8.5 Nortis Recent Development
11.9 Micronit Microtechnologies B.V.
11.9.1 Micronit Microtechnologies B.V. Company Details
11.9.2 Micronit Microtechnologies B.V. Business Overview
11.9.3 Micronit Microtechnologies B.V. Human Organs-on-Chips Introduction
11.9.4 Micronit Microtechnologies B.V. Revenue in Human Organs-on-Chips Business (2019-2024)
11.9.5 Micronit Microtechnologies B.V. Recent Development
11.10 Kirkstall
11.10.1 Kirkstall Company Details
11.10.2 Kirkstall Business Overview
11.10.3 Kirkstall Human Organs-on-Chips Introduction
11.10.4 Kirkstall Revenue in Human Organs-on-Chips Business (2019-2024)
11.10.5 Kirkstall Recent Development
11.11 Cherry Biotech SAS
11.11.1 Cherry Biotech SAS Company Details
11.11.2 Cherry Biotech SAS Business Overview
11.11.3 Cherry Biotech SAS Human Organs-on-Chips Introduction
11.11.4 Cherry Biotech SAS Revenue in Human Organs-on-Chips Business (2019-2024)
11.11.5 Cherry Biotech SAS Recent Development
11.12 Else Kooi Laboratory
11.12.1 Else Kooi Laboratory Company Details
11.12.2 Else Kooi Laboratory Business Overview
11.12.3 Else Kooi Laboratory Human Organs-on-Chips Introduction
11.12.4 Else Kooi Laboratory Revenue in Human Organs-on-Chips Business (2019-2024)
11.12.5 Else Kooi Laboratory Recent Development
11.13 Altis Biosystems
11.13.1 Altis Biosystems Company Details
11.13.2 Altis Biosystems Business Overview
11.13.3 Altis Biosystems Human Organs-on-Chips Introduction
11.13.4 Altis Biosystems Revenue in Human Organs-on-Chips Business (2019-2024)
11.13.5 Altis Biosystems Recent Development
11.14 Bi/ond
11.14.1 Bi/ond Company Details
11.14.2 Bi/ond Business Overview
11.14.3 Bi/ond Human Organs-on-Chips Introduction
11.14.4 Bi/ond Revenue in Human Organs-on-Chips Business (2019-2024)
11.14.5 Bi/ond Recent Development
11.15 Netri
11.15.1 Netri Company Details
11.15.2 Netri Business Overview
11.15.3 Netri Human Organs-on-Chips Introduction
11.15.4 Netri Revenue in Human Organs-on-Chips Business (2019-2024)
11.15.5 Netri Recent Development
11.16 Xona Microfluidics
11.16.1 Xona Microfluidics Company Details
11.16.2 Xona Microfluidics Business Overview
11.16.3 Xona Microfluidics Human Organs-on-Chips Introduction
11.16.4 Xona Microfluidics Revenue in Human Organs-on-Chips Business (2019-2024)
11.16.5 Xona Microfluidics Recent Development
11.17 SynVivo
11.17.1 SynVivo Company Details
11.17.2 SynVivo Business Overview
11.17.3 SynVivo Human Organs-on-Chips Introduction
11.17.4 SynVivo Revenue in Human Organs-on-Chips Business (2019-2024)
11.17.5 SynVivo Recent Development
11.18 Beijing Daxiang Biotech
11.18.1 Beijing Daxiang Biotech Company Details
11.18.2 Beijing Daxiang Biotech Business Overview
11.18.3 Beijing Daxiang Biotech Human Organs-on-Chips Introduction
11.18.4 Beijing Daxiang Biotech Revenue in Human Organs-on-Chips Business (2019-2024)
11.18.5 Beijing Daxiang Biotech Recent Development
11.19 AVATARGET
11.19.1 AVATARGET Company Details
11.19.2 AVATARGET Business Overview
11.19.3 AVATARGET Human Organs-on-Chips Introduction
11.19.4 AVATARGET Revenue in Human Organs-on-Chips Business (2019-2024)
11.19.5 AVATARGET Recent Development
11.20 Suzhou Jiyan Biopharmaceutical
11.20.1 Suzhou Jiyan Biopharmaceutical Company Details
11.20.2 Suzhou Jiyan Biopharmaceutical Business Overview
11.20.3 Suzhou Jiyan Biopharmaceutical Human Organs-on-Chips Introduction
11.20.4 Suzhou Jiyan Biopharmaceutical Revenue in Human Organs-on-Chips Business (2019-2024)
11.20.5 Suzhou Jiyan Biopharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 麻豆原创 Size Estimation
13.1.1.3 麻豆原创 Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
Emulate
Mimetas
TissUse
Valo Health
CN Bio Innovations
Hesperos
Draper Laboratory
Nortis
Micronit Microtechnologies B.V.
Kirkstall
Cherry Biotech SAS
Else Kooi Laboratory
Altis Biosystems
Bi/ond
Netri
Xona Microfluidics
SynVivo
Beijing Daxiang Biotech
AVATARGET
Suzhou Jiyan Biopharmaceutical
听
听
*If Applicable.
